D. Guilligay

发表

Structure and nuclear import function of the C-terminal domain of influenza virus polymerase PB2 subunit

N. Daigle, J. Ellenberg, C. Bougault, 2007, Nature Structural &Molecular Biology.

Crystal Structure of Species D Adenovirus Fiber Knobs and Their Sialic Acid Binding Sites

S. Cusack, D. Guilligay, W. Burmeister, 2004, Journal of Virology.

Host Determinant Residue Lysine 627 Lies on the Surface of a Discrete, Folded Domain of Influenza Virus Polymerase PB2 Subunit

S. Cusack, F. Tarendeau, D. Guilligay, 2008, PLoS pathogens.

Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1.

S. Cusack, D. Guilligay, R. Ravelli, 2006, RNA.

New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.

Joe D. Lewis, S. Cusack, D. Guilligay, 2013, Journal of medicinal chemistry.

An in vitro fluorescence based study of initiation of RNA synthesis by influenza B polymerase

S. Cusack, D. Guilligay, Stefan Reich, 2017, Nucleic acids research.

SARS-CoV-2 S Glycoprotein Stabilization Strategies

W. Weissenhorn, D. Guilligay, G. Effantin, 2023, Viruses.

The structural basis for cap binding by influenza virus polymerase subunit PB2

Joe D. Lewis, S. Cusack, F. Tarendeau, 2008, Nature Structural &Molecular Biology.

Structural insight into cap-snatching and RNA synthesis by influenza polymerase

Stefan Reich, Imre Berger, Max Nanao, 2014, Nature.

Structure of influenza A polymerase bound to the viral RNA promoter

S. Cusack, D. Guilligay, Stefan Reich, 2014, Nature.

Influenza Polymerase Can Adopt an Alternative Configuration Involving a Radical Repacking of PB2 Domains

Adam Round, Martin Beck, Eric Thierry, 2016, Molecular cell.

Comparative Structural and Functional Analysis of Orthomyxovirus Polymerase Cap-Snatching Domains

G. Kochs, S. Cusack, D. Guilligay, 2014, PloS one.

Self-organization of the vesicular stomatitis virus nucleocapsid into a bullet shape

D. Guilligay, R. Ruigrok, G. Schoehn, 2013, Nature Communications.

Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection

W. Weissenhorn, D. Guilligay, P. Poignard, 2021, bioRxiv.

Neutralizing Antibodies Targeting HIV-1 gp41

W. Weissenhorn, D. Guilligay, C. Caillat, 2020, Viruses.

Design, synthesis, and evaluation of N-acyl modified sialic acids as inhibitors of adenoviruses causing epidemic keratoconjunctivitis.

S. Cusack, D. Guilligay, N. Arnberg, 2009, Journal of medicinal chemistry.

Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies

A. Trkola, C. Chipot, W. Weissenhorn, 2020, bioRxiv.

Structural basis of CHMP2A–CHMP3 ESCRT-III polymer assembly and membrane cleavage

W. Roos, W. Weissenhorn, P. Bassereau, 2022, bioRxiv.

[Towards an atomic resolution understanding of the influenza virus replication machinery].

S. Cusack, D. Guilligay, R. Ruigrok, 2010, Virologie.